This track will explore the latest genomic research and its implications for diabetes management. Emphasis will be placed on how genomic data can inform personalized treatment strategies.

This session will focus on the role of pharmacogenomics in optimizing diabetes treatment. Discussions will include how genetic variations influence drug response and the potential for tailored therapies.

This track aims to identify and discuss novel biomarkers that can predict the onset of diabetes-related complications. Researchers will present findings on biomarker discovery and their clinical applications.

This session will delve into precision medicine strategies tailored for diabetes patients. The focus will be on integrating patient-specific data to enhance treatment efficacy and outcomes.

This track will investigate the underlying mechanisms of insulin resistance and its impact on diabetes progression. Presentations will cover novel therapeutic approaches aimed at improving insulin sensitivity.

This session will address the importance of patient stratification in diabetes clinical trials. Discussions will focus on methodologies for identifying subpopulations that may benefit from targeted interventions.